4.3 Article

Association of socioeconomic disadvantage and neighborhood disparities with clinical outcomes in multiple sclerosis patients

Journal

MULTIPLE SCLEROSIS AND RELATED DISORDERS
Volume 61, Issue -, Pages -

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.msard.2022.103734

Keywords

Multiple sclerosis; Area deprivation index; Socioeconomic disadvantage; Neighborhood-level disadvantage; Quality of life in neurological disorders

Funding

  1. Centers for Populations Health Research, Lerner Research Institute, Cleveland Clinic

Ask authors/readers for more resources

This study provides evidence that socioeconomic disadvantage is a risk factor for disability accrual in Multiple Sclerosis (MS) and should be targeted for improving care and resource allocation.
Background: Socioeconomic disadvantage may be an important contributor to clinical outcomes in MS but is not well understood. Our objective was to examine the associations between Area Deprivation Index (ADI), a validated measure of neighborhood-level disadvantage, with clinical outcomes. Methods: We assessed the longitudinal association between MS Performance Test (MSPT) and quality of life in Neurological Disorders (Neuro-QoL) measures with ADI quartiles (Q1: lowest deprivation - Q4 highest deprivation) in relapsing remitting MS (RRMS) and progressive MS cohorts. Results: Our study included 2,921 patients (65.8% RRMS and 34.1% progressive MS) with 13,715 visits. Patients living in the most disadvantaged areas had almost universal worsening on baseline MSPT and Neuro-QoL scores (p < 0.05) when compared to patients living in areas of lowest deprivation. Manual Dexterity Test (MDT) illustrated particular disparity as RRMS patients living in the greatest area of deprivation had MDT score which averaged 2.9 seconds longer than someone living in areas of least deprivation. Longitudinal analysis illustrated less favorable MSPT and Neuro-QoL outcomes across visits between Q1 versus Q4 ADI quartiles within in the RRMS cohort but not within the progressive MS cohort. After adjustment, linearly increasing area deprivation scores reflected less favorable Processing Speed Test (PST) and six Neuro-QoL outcomes among the RRMS cohort. Within the progressive cohort, higher deprivation was associated less favorable MDT, PST and 11 of 12 NeuroQoL outcome measures. Conclusions: This study provides evidence for socioeconomic disadvantage as a risk factor for disability accrual in MS and may be targeted to improve care while informing resource allocation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
Article Clinical Neurology

Validity and reliability of the Persian version of the trunk impairment scale in people with multiple sclerosis

Zahra Ghadimi Korka, Shohreh Noorizadeh Dehkordi, Soheil Mansour Sohani, Marzieh Yassin

Summary: The Trunk Impairment Scale (TIS) in Persian has been found to be a relevant and reliable tool for assessing trunk abnormalities in Persian-speaking people with multiple sclerosis (PWMS).

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2024)

Letter Clinical Neurology

Switching to ozanimod as a strategy to adjust fingolimod-related lymphopenia

Daniele Caliendo, Maria Carmela Grassia, Antonio Carotenuto, Maria Petracca, Roberta Lanzillo, Vincenzo Brescia Morra, Marcello Moccia

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2024)

Article Clinical Neurology

Validation of the swallowing disturbance questionnaire in people with multiple sclerosis

Maddalena Sparaco, Elisabetta Maida, Floriana Bile, Renato Vele, Luigi Lavorgna, Giuseppina Miele, Simona Bonavita

Summary: The SDQ was translated into Italian and validated for use in pwMS to detect swallowing disturbances. The 14-item SDQ demonstrated high internal consistency, good accuracy, and reliability in pwMS, making it a readily applicable tool for investigating dysphagia in MS.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2024)

Article Clinical Neurology

Impairment of daily occupations in multiple sclerosis: analysis of neuroimaging, general and social cognition, and reserve

Leticia Rodrigues Gomes, Benito Pereira Damasceno, Brunno Machado de Campos, Alfredo Damasceno

Summary: This study found that patients with multiple sclerosis (MS) have more frequent work restrictions and impairment in money management and driving abilities compared to controls. Cognitive function, physical disability, and MS lesion burden are strongly associated with work restrictions, and social cognition can influence financial capacity. Cognitive and brain reserve can help retain some of these daily occupations.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2024)

Letter Clinical Neurology

The association between sleep disorders and resilience in persons with multiple sclerosis

Kaitlin E. Riegler, John Beauvais, Lindsay O. Neto, Elizabeth S. Gromisch

Summary: This study examined the differences in resilience levels among individuals with multiple sclerosis (PwMS) who had sleep disorders, sleep problems, and no sleep disorders/problems. The results showed that PwMS with sleep disorders had significantly lower resilience, with the difference being driven by the support from family and friends. These findings highlight the connection between sleep and resilience in PwMS, emphasizing the importance of social support.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2024)

Article Clinical Neurology

Frequency and risk factors of rebound after fingolimod discontinuation - A retrospective study

A. Maunula, S. Atula, Sm Laakso, Pj Tienari

Summary: This study aimed to investigate the frequency and risk factors of FTY rebound in a hospital district in Southern Finland. The results showed that 10.5% of patients experienced a rebound, and 28% of patients had relapses of any severity after discontinuing FTY. Younger age at diagnosis, longer exposure to FTY, lower lymphocyte count, and higher neutrophil to lymphocyte ratio after discontinuation were identified as risk factors for a rebound.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2024)